Can a simple RNA test predict pancreatic cancer outcomes?
NCT ID NCT04765410
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined small RNA molecules called microRNAs in tissue samples from 57 people with pancreatic cancer. The samples were collected during a routine endoscopic ultrasound procedure. Researchers aimed to see if certain microRNA patterns are linked to how aggressive the cancer is, how long patients live, and how they respond to treatment. The goal is to eventually use this information to personalize care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"Carol Davila" University Central Emergency Hospital
Bucharest, Sector 1, 010825, Romania
-
"Prof Dr Agrippa Ionescu" Emergency Hospital
Bucharest, Sector 1, 011356, Romania
-
"Victor Babes" National Pathology Institute
Bucharest, Sector, 050096, Romania
-
Clinical Emergency Hospital Bucharest
Bucharest, Sector 1, 014461, Romania
-
Fundeni Clinical Institute
Bucharest, Sector 2, 022328, Romania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill rouse the immune system against pancreatic cancer?
- A sound wave that could expose hidden pancreatic cancer?
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- Targeted chemotherapy pump takes fight directly to pancreatic cancer liver tumors
- Light-Activated therapy targets pancreatic tumors during surgery
- Engineered immune cells take aim at Mesothelin-Positive tumors